 WIXOM, Mich., Jan. 07, 2022 GLOBE NEWSWIRE -- Rockwell Medical, Inc. Nasdaq: RMTI Rockwell Medical or the Company, a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management and improving outcomes for patients around the world, today announced the Rockwell Medical executive management team is scheduled to present at the H.C. Wainwright BioConnect 2022 Conference. 